Forward Ventures is throwing its hat in the ring of life science VCs pursuing an asset-based business model to generate returns. The firm is looking to raise $100-$200 million for a new fund - Forward Medical Science Partners (FoMS) L.P. - that will be solely dedicated to the investment strategy.

Stan Fleming, a managing member and co-founder of Forward Ventures, said the fund is a break from the firm's more traditional investment strategy